Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment
The aim of the study was the evaluation of the suitability of 5-oxo-2-pyrrolidinecarboxylic acid (PCA), also in combination with hyaluronic acid (HA), as artificial tears for treatment of dry eye syndrome (DES). Different aqueous formulations containing 0.10% w/w of PCA were used to determine: (i) e...
Main Authors: | Silvia Tampucci, Daniela Monti, Susi Burgalassi, Eleonora Terreni, Erica Zucchetti, Filippo Baldacci, Patrizia Chetoni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/10/3/137 |
Similar Items
-
Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A
by: Eleonora Terreni, et al.
Published: (2020-03-01) -
Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease
by: Mateo Orobia AJ, et al.
Published: (2018-03-01) -
Combination of Nanomicellar Technology and In Situ Gelling Polymer as Ocular Drug Delivery System (ODDS) for Cyclosporine-A
by: Eleonora Terreni, et al.
Published: (2021-02-01) -
Reaction of nucleic acid components with oxo-osmium compounds /
by: Daniel, Francis Bernard
Published: (1974) -
Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
by: Aragona P, et al.
Published: (2020-10-01)